Frequency of spontaneous resistance to fosfomycin combined with different antibiotics in Pseudomonas aeruginosa

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 11, 2010, Pages 4948-4949

  Rodríguez Rojas, Alexandro ^a   Couce, Alejandro ^a   Blázquez, Jesús ^a  

^a CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; FOSFOMYCIN; IMIPENEM; MEROPENEM; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; DRUG EFFICACY; DRUG TREATMENT FAILURE; IN VITRO STUDY; LETTER; MUCUS SECRETION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; FOSFOMYCIN; MUTATION; PSEUDOMONAS AERUGINOSA;

EID: 78049275799     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00415-10     Document Type: Letter

References (15)

1. CLSI. 2006. CLSI methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard, 7th ed. CLSI M7-A7. Clinical and Laboratory Standards Institute, Wayne, PA.
2. Falagas, M. E., A. P. Grammatikos, and A. Michalopoulos. 2008. Potential of old-generation antibiotics to address current need for new antibiotics. Expert Rev. Anti Infect. Ther. 6:593-600.
3. Faruqi, S., J. McCreanor, T. Moon, R. Meigh, and A. H. Morice. 2008. Fosfomycin for Pseudomonas-related exacerbations of cystic fibrosis. Int. J. Antimicrob. Agents 32:461-463.
4. Liberati, N. T., J. M. Urbach, S. Miyata, D. G. Lee, E. Drenkard, G. Wu, J. Villanueva, T. Wei, and F. M. Ausubel. 2006. An ordered, nonredundant library of Pseudomonas aeruginosa strain PA14 transposon insertion mutants. Proc. Natl. Acad. Sci. U. S. A. 103:2833-2838.
5. Livermore, D. M. 2002. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? Clin. Infect. Dis. 34:634-640.
6. Macia, M. D., D. Blanquer, B. Togores, J. Sauleda, J. L. Perez, and A. Oliver. 2005. Hypermutation is a key factor in development of multiple-antimicrobial resistance in Pseudomonas aeruginosa strains causing chronic lung infections. Antimicrob. Agents Chemother. 49:3382-3386.
7. MacLeod, D. L., L. M. Barker, J. L. Sutherland, S. C. Moss, J. L. Gurgel, T. F. Kenney, J. L. Burns, and W. R. Baker. 2009. Antibacterial activities of a fosfomycin/tobramycin combination: a novel inhaled antibiotic for bronchiectasis. J. Antimicrob. Chemother. 64:829-836.
8. Mena, A., E. E. Smith, J. L. Burns, D. P. Speert, S. M. Moskowitz, J. L. Perez, and A. Oliver. 2008. Genetic adaptation of Pseudomonas aeruginosa to the airways of cystic fibrosis patients is catalyzed by hypermutation. J. Bacteriol. 190:7910-7917.
9. Mikuniya, T., Y. Kato, T. Ida, K. Maebashi, K. Monden, R. Kariyama, and H. Kumon. 2007. Treatment of Pseudomonas aeruginosa biofilms with a combination of fluoroquinolones and fosfomycin in a rat urinary tract infection model. J. Infect. Chemother. 13:285-290.
10. Oliver, A., R. Canton, P. Campo, F. Baquero, and J. Blazquez. 2000. High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science 288:1251-1254.
11. Pruekprasert, P., and W. Tunyapanit. 2005. In vitro activity of fosfomycin-gentamicin, fosfomycin-ceftazidime, fosfomycin-imipenem and ceftazidime-gentamicin combinations against ceftazidime-resistant Pseudomonas aeruginosa. Southeast Asian J. Trop. Med. Public Health 36:1239-1242.
12. Rodriguez-Rojas, A., and J. Blazquez. 2009. The Pseudomonas aeruginosa pfpI gene plays an antimutator role and provides general stress protection. J. Bacteriol. 191:844-850.
13. Rodriguez-Rojas, A., M. D. Macia, A. Couce, C. Gomez, A. Castaneda-Garcia, A. Oliver, and J. Blazquez. 2010. Assessing the emergence of resistance: the absence of biological cost in vivo may compromise fosfomycin treatments for P. aeruginosa infections. PLoS One 5:e10193.
14. Tummler, B., J. Bosshammer, S. Breitenstein, I. Brockhausen, P. Gudowius, C. Herrmann, S. Herrmann, T. Heuer, P. Kubesch, F. Mekus, U. Romling, K. D. Schmidt, C. Spangenberg, and S. Walter. 1997. Infections with Pseudomonas aeruginosa in patients with cystic fibrosis. Behring Inst. Mitt. 98:249-255.
15. Yamada, S., Y. Hyo, S. Ohmori, and M. Ohuchi. 2007. Role of ciprofloxacin in its synergistic effect with fosfomycin on drug-resistant strains of Pseudomonas aeruginosa. Chemotherapy 53:202-209.